EGCG, a compound in green tea, sticks to the liver’s enzyme COMT much tighter than EGC, another tea compound—but once it’s stuck, it gets processed much more slowly.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim reports precise kinetic parameters (Km and Vmax) derived from in vitro enzyme assays, which are standard and reliable methods for characterizing enzyme-substrate interactions. These values are quantitative and reproducible under controlled conditions, making a definitive statement appropriate. The claim does not overgeneralize to in vivo effects or health outcomes, and correctly distinguishes between binding affinity and catalytic rate.
More Accurate Statement
“In human liver cytosol, epigallocatechin gallate (EGCG) exhibits a lower Michaelis constant (Km = 0.16 µM) and a lower maximum reaction rate (Vmax = 0.16 nmol/mg/min) compared to epigallocatechin (EGC) (Km = 4.0 µM, Vmax = 1.28 nmol/mg/min), indicating that EGCG has higher binding affinity but slower catalytic turnover by catechol-O-methyltransferase (COMT).”
Context Details
Domain
biochemistry
Population
in_vitro
Subject
EGCG and EGC
Action
exhibit
Target
lower Michaelis constant (Km) and lower maximum reaction rate (Vmax) for COMT in human liver cytosol
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.
The study found that EGCG sticks to the enzyme better than EGC but gets processed slower — just like the claim says. The numbers from the study match the claim exactly.